Cargando…
Cost-effectiveness analysis of oral anti-viral drugs used for treatment of chronic hepatitis B in Turkey
BACKGROUND: All international guidelines suggested that Tenofovir and Entecavir are the primary drugs at the first line therapy for the treatment of chronic hepatitis B (CHB). However, in Turkey these medications reimbursed at the second line therapy according to the Healthcare Implementation Notifi...
Autores principales: | Kockaya, Guvenc, Kose, Akin, Yenilmez, Fatma Betul, Ozdemir, Oktay, Kucuksayrac, Ece |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4674927/ https://www.ncbi.nlm.nih.gov/pubmed/26664289 http://dx.doi.org/10.1186/s12962-015-0046-8 |
Ejemplares similares
-
Changes in Catastrophic Health Expenditures Depending on Health Policies in Turkey
por: Kockaya, Guvenc, et al.
Publicado: (2021) -
Analysis of patient access to orphan drugs in Turkey
por: Koçkaya, Güvenç, et al.
Publicado: (2021) -
PIN56 Cost of COVID-19 Patients Treatment in Turkey
por: Karahan, E.B., et al.
Publicado: (2020) -
Seroprevalence of Hepatitis B and C among Oncology Patients in Turkey
por: Kose, Sukran, et al.
Publicado: (2011) -
Cost-Effectiveness Analysis of the Triclip™ Transcatheter Tricuspid Valve Repair System in Patients with Tricuspid Regurgitation
por: Kurnaz, Mustafa, et al.
Publicado: (2022)